COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2936: Articles 29351-29360  | Next

Genomics of Indian SARS-CoV-2: Implications in genetic diversity, possible origin and spread of virus
Somasundaram, K., Mondal, M., Lawarde, A.
10.1101/2020.04.25.20079475 — Posted: 2020-04-29
Novel indicator of change in COVID-19 spread status
Nakano, T., Ikeda, Y.
10.1101/2020.04.25.20080200 — Posted: 2020-04-29 Discussion: Onsite | Offsite
Systematic review of international guidelines for tracheostomy in COVID-19 patients.
Chiesa-Estomba, C. M., Lechien, J. R., Calvo-Henriquez, C., Fakhry, N., Karkos, P. D., Peer, S., Sistiaga-Suarez, J. A., Gonzalez-Garcia, J. A., Cammaroto, G., Mayo, M., Parente-Arias, P., Saussez, S., Ayad, T.
10.1101/2020.04.26.20080242 — Posted: 2020-04-29
Mass spectrometry analysis of newly emerging coronavirus HCoV-19 spike S protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications
Sun, Z., Ren, K., Zhang, X., Chen, J., Jiang, Z., Jiang, J., Ji, F., Ouyang, X., Li, L.
10.1101/2020.04.29.068098 — Posted: 2020-04-29 Discussion: Onsite | Offsite
An engineered stable mini-protein to plug SARS-Cov2 Spikes
Romano, M., Ruggiero, A., Squeglia, F., Berisio, R.
10.1101/2020.04.29.067728 — Posted: 2020-04-29
SARS-CoV-2 Spike S1 Receptor Binding Domain undergoes Conformational Change upon Interaction with Low Molecular Weight Heparins.
Mycroft-West, C., Su, D., Li, Y., Guimond, S., Rudd, T., Elli, S., Miller, G., Nunes, Q., Procter, P., Bisio, A., Forsyth, N., Turnbull, J., Guerrini, M., Fernig, D., Yates, E., Lima, M., Skidmore, M.
10.1101/2020.04.29.068486 — Posted: 2020-04-29
Activity profiling of SARS-CoV-2-PLpro protease provides structural framework for anti-COVID-19 drug design
Rut, W., Zmudzinski, M., Lyu, Z., Nayak, D., Snipas, S. J., Bekes, M., Huang, T. T., Olsen, S. K., Drag, M.
10.1101/2020.04.29.068890 — Posted: 2020-04-29
Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain.
Mycroft-West, C., Su, D., Li, Y., Guimond, S., Rudd, T., Elli, S., Miller, G., Nunes, Q., Procter, P., Bisio, A., Forsyth, N., Turnbull, J., Guerrini, M., Fernig, D., Yates, E., Lima, M., Skidmore, M.
10.1101/2020.04.29.068767 — Posted: 2020-04-29
A collection of designed peptides to target SARS-Cov-2 - ACE2 interaction: PepI-Covid19 database.
Molina, R., Oliva, B., Fernandez-Fuentes, N.
10.1101/2020.04.28.051789 — Posted: 2020-04-29
Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India
BEGUM, F., MUKHERJEE, D., THAKRIKI, D., DAS, S., TRIPATHI, P. P., BANERJEE, A. K., RAY, U.
10.1101/2020.04.28.066985 — Posted: 2020-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).